Efficacy of sodium glucose cotransporter 2 inhibitors on hepatic fibrosis and steatosis in non-alcoholic fatty liver disease: an updated systematic review and meta-analysis. The gene discussed is SLC5A2; the disease is metabolic dysfunction-associated steatotic liver disease.